Perceive Biotherapeutics, Inc.
PrivateLast Round
Series B
Jan 5, 2023
Total Funding Raised
$78M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Perceive Biotherapeutics, Inc. is a biotechnology company that develops gene therapies and other innovative therapeutics for the treatment of ocular diseases such as age-related macular degeneration and glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perceive Biotherapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Perceive Biotherapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 5, 2023 | ||||
| Series A | Aug 1, 2018 |
Key People
Founding team and executive leadership
Perceive Biotherapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A, Series B |
| Braidwell | Series B |
| Catalio Capital Management | Series B |
| Foundation Fighting Blindness | Series B |
| Johnson & Johnson Innovation – JJDC | Series B |
| Johnson & Johnson Innovation - JJDC, Inc. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 98% MoM.
- Dec 1, 2025
Lead gene therapy program in ophthalmology enters Phase 2 trials.
Perceive Biotherapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Perceive Biotherapeutics, Inc.'s valuation, stock price, and market status.